Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Clinical trial NCT05712694 · TERMINATED

Trial details

NCT number: NCT05712694
Sponsor: Polaris Group
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2023-11-29
Primary completion: 2026-05-25
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.